{"id":3925,"date":"2016-04-05T08:42:49","date_gmt":"2016-04-05T06:42:49","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/"},"modified":"2020-06-26T14:32:09","modified_gmt":"2020-06-26T12:32:09","slug":"lamnar-in-tva-nya-patentansokningar","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/","title":{"rendered":"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/p>\n<p><span><em>Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar som l\u00e4mnas in till det Europeiska patentverket, EPO. B\u00e5da patentans\u00f6kningarna g\u00e4ller nya produkter och metoder som \u00e4r kopplade till Nanexas drug delivery-system PharmaShell\u00ae.<\/em><\/span><\/p>\n<p><\/strong><\/div>\n<p><span>Det senaste \u00e5rets arbete med PharmaShell\u00ae har lett till flera tekniska framsteg, inom befintliga men ocks\u00e5 inom nya produktomr\u00e5den och d\u00e4rf\u00f6r har Nanexa beslutat att l\u00e4mna in tv\u00e5 nya patentans\u00f6kningar.<\/span><\/p>\n<p><span>Patentans\u00f6kningarna avser nya produkter, metoder och anv\u00e4ndningsomr\u00e5den inom ramen f\u00f6r drug delivery-systemet PharmaShell\u00ae och de l\u00e4mnades in vid det Europeiska patentverket (EPO) den 5 april 2016. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de europeiska patentans\u00f6kningarna med internationella patentans\u00f6kningar (PCT-ans\u00f6kningar) vilket Nanexa \u00e4mnar g\u00f6ra.<\/span><\/p>\n<p><span>Nanexas VD David Westberg s\u00e4ger att immateriella r\u00e4ttigheter i allm\u00e4nhet och patent i synnerhet \u00e4r v\u00e4ldigt viktigt f\u00f6r Nanexas verksamhet. \u201dGenom de h\u00e4r tv\u00e5 nya patentans\u00f6kningarna f\u00f6rst\u00e4rker vi skyddet kring PharmaShell\u00ae och dessutom ger de oss m\u00f6jlighet att komma in p\u00e5 helt nya aff\u00e4rsomr\u00e5den med v\u00e5rt drug delivery-system.\u201d<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<\/span><\/p>\n<p><span>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<\/span><\/p>\n<p><span>?Telefon: 0709 -42 83 03?<\/span><\/p>\n<p><span>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\" rel=\"nofollow\">david.westberg@nanexa.se<\/a><\/span><\/p>\n<p><span><a href=\"http:\/\/www.nanexa.se\/\" rel=\"nofollow\">www.nanexa.se<\/a><\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Uppsala universitet.<\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/aktietorget.blob.core.windows.net\/press\/news\/nanexa\/77626\/496613.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar som l\u00e4mnas in till det Europeiska patentverket, EPO. B\u00e5da patentans\u00f6kningarna g\u00e4ller nya produkter och metoder som \u00e4r kopplade till Nanexas drug delivery-system PharmaShell\u00ae.<\/p>\n","protected":false},"template":"","class_list":["post-3925","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar som l\u00e4mnas in till det Europeiska patentverket, EPO. B\u00e5da patentans\u00f6kningarna g\u00e4ller nya produkter och metoder som \u00e4r kopplade till Nanexas drug delivery-system PharmaShell\u00ae.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:32:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lamnar-in-tva-nya-patentansokningar\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lamnar-in-tva-nya-patentansokningar\\\/\",\"name\":\"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-04-05T06:42:49+00:00\",\"dateModified\":\"2020-06-26T12:32:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lamnar-in-tva-nya-patentansokningar\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/","og_locale":"sv_SE","og_type":"article","og_title":"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","og_description":"Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar som l\u00e4mnas in till det Europeiska patentverket, EPO. B\u00e5da patentans\u00f6kningarna g\u00e4ller nya produkter och metoder som \u00e4r kopplade till Nanexas drug delivery-system PharmaShell\u00ae.","og_url":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:32:09+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/","url":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/","name":"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-04-05T06:42:49+00:00","dateModified":"2020-06-26T12:32:09+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/lamnar-in-tva-nya-patentansokningar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"L\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}